Accelerating Drug/Tracer Development

Our AI-driven software technologies provide comprehensive treatment response assessments from imaging scans to improve patient outcomes.
Learn More
"Partnering with AIQ Solutions on their new technology has been an enjoyable and productive collaboration. We share a mutual goal of improving patient care by leveraging innovative technology."
Dr. Elisabeth I. Heath, M.D., FACP

Professor of Oncology and Medicine
Karmanos Cancer Institute

"The AIQ software will greatly improve the interpretation of PET/CT and PET/MRI scans in patients who have had multiple exams. The analysis of these exams will be more thorough and comprehensive and should save the interpreting nuclear medicine physician or radiologist a lot of time.

The ability to determine which lesions have responded to therapy and which are resistant in patients with a large metastatic disease burden will allow great improvements in patient care and hopefully lead to improved survival in oncology patients. Software like this will surely be an important part of image interpretation in the future."
Dr. Scott Perlman M.D., M.S.

Associate Section Chief, UW Nuclear Medicine & Molecular Imaging
University of Wisconsin School of Medicine and Public Health
Consultant to AIQ

RALEIGH, N.C., June 9, 2022 /PRNewswire/ -- Lucem Health™ today launched the Lucem Health Innovation Collaborative, a partner program designed to move clinical AI/ML innovation to the front lines of healthcare. The Collaborative will help digital health innovators create, deploy, and commercialize transformational solutions powered by artificial intelligence and machine learning models.

Learn more about

AIQ Solutions

For more information on AIQ treatment response solutions, or to schedule a demo